Latest Varian Medical Systems Stories
BEIJING, Sept. 11, 2012 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the world's leading manufacturer of medical technology for treating cancer with radiotherapy, announced today that China's State Food and Drug Administration (SFDA) has granted clearance to market the UNIQUE(TM) medical linear accelerator, a single-energy machine for treating cancer with advanced forms of image-guided radiotherapy. The versatile UNIQUE system can be used to deliver intensity-modulated...
PARIS, Sept. 4, 2012 /PRNewswire/ -- Four advanced radiotherapy treatment systems from Varian Medical Systems (NYSE: VAR) have been ordered by Institut Curie, one of Europe's foremost comprehensive cancer centers, to replace older and less capable machines. Institut Curie, which operates at three sites in Paris, is acquiring three Varian TrueBeam(TM) systems and a Novalis Tx(TM) machine to extend the range of modern cancer treatments offered to patients. The largest hospital in...
SEOUL, South Korea, Aug. 23, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy and radiosurgery, is strengthening its leadership position in South Korea by establishing an in-country subsidiary. Varian Medical Systems Korea, based in Seoul, will support the launch and rollout of the company's TrueBeam(TM) treatment system while, over time, providing a local base for all the company's business units. "South Korea is a vibrant and growing...
PALO ALTO, Calif., Aug. 21, 2012 /PRNewswire/ -- Cancer patients in Vietnam, a country of 88.5 million people, will get expanded access to advanced radiotherapy treatment using technology from Varian Medical Systems (NYSE: VAR) as a result of close cooperation between the company, the US Embassy in Vietnam and Vietnamese partners. Da Nang Cancer Hospital has contracted with Varian to provide a radiotherapy system capable of delivering intensity-modulated radiotherapy treatments...
PALO ALTO, Calif., Aug. 15, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that it has become a supporter of a phase III study comparing radiosurgery with surgical resection for the treatment of early-stage, high-risk, operable non-small cell lung cancer. The study, which will take place over the next eight years, will look at patients' overall, disease-free, and regional recurrence-free survival rates three years after treatment, and also adverse events and...
PALO ALTO, Calif., Aug. 13, 2012 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE:VAR) today announced that its Board of Directors has authorized the company to repurchase an additional 8 million shares of its common stock between September 29, 2012 and December 31, 2013. Stock repurchases may be made in the open market, in privately negotiated transactions including accelerated share repurchase programs, or in Rule 10b5-1 share repurchase plans, and also may be made from time to...
PALO ALTO, Calif., Aug. 13, 2012 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE:VAR) today announced that Erich R. Reinhardt, Ph.D., former President and CEO of Siemens Healthcare, has been appointed to the Board of Directors, effective August 10, 2012. Reinhardt, 65, served in management roles at Siemens Healthcare (formerly Siemens Medical Solutions), including President and CEO from 1994 to 2008. He is currently Chairman of Medical Valley Europaische Metropol Region in...
PALO ALTO, Calif., Aug. 13, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) today announced that Timothy E. Guertin has declared his intention to retire as the company's President and CEO at the end of the company's current fiscal year on September 28, 2012. Varian's Board of Directors has elected Dow R. Wilson, 53, the company's current Executive Vice President and Chief Operating Officer, to become Varian's President and CEO upon Guertin's retirement. The board also...
CHENNAI, India, July 26, 2012 /PRNewswire/ -- Cancer treatments have commenced in Chennai using the city's first TrueBeam(TM) STx system for radiotherapy and radiosurgery from Varian Medical Systems (NYSE: VAR). The first patient was a 36-year-old male with rectal cancer who received intensity modulated radiotherapy (IMRT) last week at MIOT Hospital using the fast and precise system. "Our TrueBeam STx system offers high precision treatments that can be delivered in a very short...
PALO ALTO, Calif., July 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is today reporting net earnings of $0.96 per diluted share in the third quarter of fiscal year 2012, up 16 percent from $0.83 in the year-ago quarter. Revenues for the quarter were $705 million, up 9 percent from the year-ago quarter. "All of our major businesses contributed to solid growth in earnings and revenues," said Tim Guertin, president and CEO of Varian Medical Systems. "Gross margins...
